Topics
-
Introducing "Sysmex Smart Work" to Promote Work Style Reform under the “New Normal”
-
Our Response to the Coronavirus Disease 2019
-
Sysmex Launches Official Account on LinkedIn
-
Business Results Announcement for the Fiscal Year Ended March 31, 2021 (See Latest Financial Statements)
-
Initiatives to Improve Access to Medical Services and Develop Human Resources Around the World
-
Dedicated to Eliminating Malaria Through the Development of Diagnostic Devices
Press Releases
-
Sysmex Obtains IVDR Certification for LYNOAMP™ CK19 E, a Gene Amplification Detection Reagent
- Prompt response to legislative changes in the European region that demand greater product safety - (PDF：184KB) - Th2 Chemokine TARC Kit "HISCL™ TARC Assay Kit" is Approved for an Additional Indication as an Auxiliary for Assessment of COVID-19 Aggravation risk (PDF：210KB)
- Sysmex Relocates its PCR Testing Laboratory to its Research and Development Center for Expanded Functions (PDF：154KB)
- Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
- Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2021 (PDF：174KB)
